Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Very long chain fatty acids (VLCFAs) are essential building blocks for the synthesis of ceramides and sphingolipids. The first step in the fatty acid elongation cycle is catalyzed by the 3-keto acyl-coenzyme A (CoA) synthases (in mammals, ELOVL elongases). Although ELOVLs are implicated in common diseases, including insulin resistance, hepatic steatosis and Parkinson's, their underlying molecular mechanisms are unknown. Here we report the structure of the human ELOVL7 elongase, which comprises an inverted transmembrane barrel surrounding a 35-Å long tunnel containing a covalently attached product analogue. The structure reveals the substrate-binding sites in the narrow tunnel and an active site deep in the membrane. We demonstrate that chain elongation proceeds via an acyl-enzyme intermediate involving the second histidine in the canonical HxxHH motif. The unusual substrate-binding arrangement and chemistry suggest mechanisms for selective ELOVL inhibition, relevant for diseases where VLCFAs accumulate, such as X-linked adrenoleukodystrophy.

Original publication

DOI

10.1038/s41594-021-00605-6

Type

Journal article

Journal

Nat Struct Mol Biol

Publication Date

06/2021

Volume

28

Pages

512 - 520

Keywords

Adrenoleukodystrophy, Animals, Binding Sites, Catalytic Domain, Cloning, Molecular, Coenzyme A, Crystallography, X-Ray, Fatty Acid Elongases, Fatty Acids, HEK293 Cells, Histidine, Humans, Imidazoles, Models, Molecular, Protein Binding, Protein Conformation, Recombinant Proteins, Sf9 Cells, Spectrometry, Mass, Electrospray Ionization, Structure-Activity Relationship, Substrate Specificity